113 related articles for article (PubMed ID: 37776914)
21. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH
Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970
[TBL] [Abstract][Full Text] [Related]
22. Restrictive pulmonary dysfunction at spirometry and mortality in the elderly.
Scarlata S; Pedone C; Fimognari FL; Bellia V; Forastiere F; Incalzi RA
Respir Med; 2008 Sep; 102(9):1349-54. PubMed ID: 18599282
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Forced and Slow Vital Capacity Maneuvers in Defining Airway Obstruction.
Huprikar NA; Skabelund AJ; Bedsole VG; Sjulin TJ; Karandikar AV; Aden JK; Morris MJ
Respir Care; 2019 Jul; 64(7):786-792. PubMed ID: 30890630
[TBL] [Abstract][Full Text] [Related]
24. Rapid FEV
Choi KY; Lee HJ; Lee JK; Park TY; Heo EY; Kim DK; Lee HW
J Korean Med Sci; 2023 Jan; 38(1):e4. PubMed ID: 36593688
[TBL] [Abstract][Full Text] [Related]
25. Implications of adopting the Global Lungs Initiative 2012 all-age reference equations for spirometry.
Quanjer PH; Brazzale DJ; Boros PW; Pretto JJ
Eur Respir J; 2013 Oct; 42(4):1046-54. PubMed ID: 23520323
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis.
Higbee DH; Granell R; Davey Smith G; Dodd JW
Lancet Respir Med; 2022 Feb; 10(2):149-157. PubMed ID: 34739861
[TBL] [Abstract][Full Text] [Related]
27. Diffuse Idiopathic Skeletal Hyperostosis in Smokers and Restrictive Spirometry Pattern: An Analysis of the COPDGene Cohort.
Oudkerk SF; Mohamed Hoesein FAA; Öner FC; Verlaan JJ; de Jong PA; Kuperus JS; Cho M; McDonald ML; Lynch DA; Silverman EK; Crapo JD; Make BJ; Lowe KE; Regan EA
J Rheumatol; 2020 Apr; 47(4):531-538. PubMed ID: 31043539
[TBL] [Abstract][Full Text] [Related]
28. FEV1 and FVC predict all-cause mortality independent of cardiac function - Results from the population-based Gutenberg Health Study.
Magnussen C; Ojeda FM; Rzayeva N; Zeller T; Sinning CR; Pfeiffer N; Beutel M; Blettner M; Lackner KJ; Blankenberg S; Münzel T; Rabe KF; Wild PS; Schnabel RB;
Int J Cardiol; 2017 May; 234():64-68. PubMed ID: 28214081
[TBL] [Abstract][Full Text] [Related]
29. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study.
Guerra S; Sherrill DL; Venker C; Ceccato CM; Halonen M; Martinez FD
Thorax; 2010 Jun; 65(6):499-504. PubMed ID: 20522846
[TBL] [Abstract][Full Text] [Related]
30. Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study.
Toren K; Schiöler L; Lindberg A; Andersson A; Behndig AF; Bergström G; Blomberg A; Caidahl K; Engvall J; Eriksson M; Hamrefors V; Janson C; Kylhammar D; Lindberg E; Lindén A; Malinovschi A; Persson HL; Sandelin M; Eriksson Ström J; Tanash HA; Vikgren J; Östgren CJ; Wollmer P; Sköld CM
BMJ Open Respir Res; 2020 Aug; 7(1):. PubMed ID: 32759170
[TBL] [Abstract][Full Text] [Related]
31. Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
Sumida K; Kwak L; Grams ME; Yamagata K; Punjabi NM; Kovesdy CP; Coresh J; Matsushita K
Am J Kidney Dis; 2017 Nov; 70(5):675-685. PubMed ID: 28754455
[TBL] [Abstract][Full Text] [Related]
32. Restrictive spirometry versus restrictive lung function using the GLI reference values.
Myrberg T; Lindberg A; Eriksson B; Hedman L; Stridsman C; Lundbäck B; Rönmark E; Backman H
Clin Physiol Funct Imaging; 2022 May; 42(3):181-189. PubMed ID: 35225428
[TBL] [Abstract][Full Text] [Related]
33. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6.
Vandevoorde J; Verbanck S; Schuermans D; Kartounian J; Vincken W
Eur Respir J; 2006 Feb; 27(2):378-83. PubMed ID: 16452596
[TBL] [Abstract][Full Text] [Related]
34. A Comparison of Global Lung Initiative 2012 with Third National Health and Nutrition Examination Survey Spirometry Reference Values. Implications in Defining Obstruction.
Huprikar NA; Holley AB; Skabelund AJ; Hayes JA; Hiles PD; Aden JK; Morris MJ; Hersh AM
Ann Am Thorac Soc; 2019 Feb; 16(2):225-230. PubMed ID: 30427734
[TBL] [Abstract][Full Text] [Related]
35. Impact of restrictive versus obstructive pulmonary function patterns on mortality in patients undergoing transcatheter aortic valve implantation.
Escárcega RO; Torguson R; Tavil-Shatelyan A; Daoud Y; Koifman E; Kiramijyan S; Gai J; Satler LF; Pichard AD; Waksman R
Cardiovasc Revasc Med; 2016; 17(3):181-5. PubMed ID: 26997471
[TBL] [Abstract][Full Text] [Related]
36. Preserved ratio impaired spirometry with or without restrictive spirometric abnormality.
Miura S; Iwamoto H; Omori K; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Fujitaka K; Hamada H; Yokoyama A; Hattori N
Sci Rep; 2023 Feb; 13(1):2988. PubMed ID: 36806707
[TBL] [Abstract][Full Text] [Related]
37. Restrictive spirometric pattern and true pulmonary restriction in a general population sample aged 50 - 64 years.
Torén K; Schiöler L; Brisman J; Malinovschi A; Olin AC; Bergström G; Bake B
BMC Pulm Med; 2020 Feb; 20(1):55. PubMed ID: 32106839
[TBL] [Abstract][Full Text] [Related]
38. Spirometric patterns in young and middle-aged adults: a 20-year European study.
Carsin AE; Garcia-Aymerich J; Accordini S; Dharmage S; Leynaert B; de Las Heras M; Casas L; Caviezel S; Demoly P; Forsberg B; Gislason T; Corsico AG; Janson C; Jogi R; Martínez-Moratalla J; Nowak D; Gómez LP; Pin I; Probst-Hensch N; Raherison-Semjen C; Squillacioti G; Svanes C; Torén K; Urrutia I; Huerta I; Anto JM; Jarvis D; Guerra S
Thorax; 2024 Jan; 79(2):153-162. PubMed ID: 37758456
[TBL] [Abstract][Full Text] [Related]
39. Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers.
Wan ES; Hokanson JE; Regan EA; Young KA; Make BJ; DeMeo DL; Mason SE; San Jose Estepar R; Crapo JD; Silverman EK
Chest; 2022 Mar; 161(3):651-661. PubMed ID: 34592319
[TBL] [Abstract][Full Text] [Related]
40. Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study.
Kubota Y; London SJ; Cushman M; Chamberlain AM; Rosamond WD; Heckbert SR; Zakai N; Folsom AR
J Thromb Haemost; 2016 Dec; 14(12):2394-2401. PubMed ID: 27696765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
